Over the past 12 months, 2 insiders at OnKure Therapeutics, Inc. filed 6 open-market SEC Form 4 transactions on OKUR: 0 purchases worth $0 and 6 sales worth $4K. Insiders have been net sellers over this period. The most recent filing was on Mar 23, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 26 | Jason A. LeveroneChief Financial Officer | SELL | 301 | $4.16 | $1K |
| Mar 23, 26 | Nicholas A SaccomanoPresident and CEO | SELL | 86 | $4.16 | $358 |
| Dec 22, 25 | Jason A. LeveroneChief Financial Officer | SELL | 302 | $2.97 | $897 |
| Dec 22, 25 | Nicholas A SaccomanoPresident and CEO | SELL | 87 | $2.97 | $258 |
| Sep 22, 25 | Jason A. LeveroneChief Financial Officer | SELL | 303 | $2.62 | $794 |
| Sep 22, 25 | Nicholas A SaccomanoPresident and CEO | SELL | 88 | $2.62 | $231 |
| Jun 23, 25 | Jason A. LeveroneChief Financial Officer | SELL | 303 | $2.38 | $721 |
| Jun 23, 25 | Nicholas A SaccomanoPresident and CEO | SELL | 88 | $2.38 | $209 |
| May 15, 25 | Acorn Capital Advisors Gp, LlcTenPercentOwner | BUY | 1.13M | $1.85 | $2.1M |
| May 15, 25 | Cormorant Private Healthcare Fund III LpOther | SELL | 1.81M | $1.85 | $3.4M |
| May 12, 25 | Cormorant Global Healthcare Master Fund, LpTenPercentOwner | SELL | 24.3K | $1.99 | $48K |
| Apr 7, 25 | Jason A. LeveroneChief Financial Officer | SELL | 1.8K | $2.67 | $5K |
| Apr 7, 25 | Nicholas A SaccomanoPresident and CEO | SELL | 516 | $2.67 | $1K |
| Apr 4, 25 | Jason A. LeveroneChief Financial Officer | SELL | 1.3K | $3.33 | $4K |
| Apr 4, 25 | Nicholas A SaccomanoPresident and CEO | SELL | 358 | $3.33 | $1K |
Over the past 12 months, insiders at OnKure Therapeutics, Inc. filed 0 open-market purchases worth $0 and 6 sales worth $4K on OKUR, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 23, 26.
The largest recent open-market OKUR insider purchase in our data was $2.1M by Acorn Capital Advisors Gp, Llc, TenPercentOwner, filed on May 15, 25.
2 different insiders at OnKure Therapeutics, Inc. filed open-market SEC Form 4 transactions on OKUR over the last 12 months.
InsiderTape plots every OKUR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every OnKure Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →